David Kirn, Chief Executive Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 39,048 shares at $20.19 ($785K) on 2023-01-20, disclosed to the SEC on 2023-01-23.
Open-market sale of $785k FDMT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.03 | 10,899 | $218K | 27.8% |
| 2 | $20.03 | 10,899 | $218K | 27.8% |
| 3 | $20.19 | 8,625 | $174K | 22.2% |
| 4 | $20.19 | 8,625 | $174K | 22.2% |
| Total | $20.10 avg | 39,048 | $785K | 100% |
| Filing → |
| FDMT | SELL | 2026-08-05 | $275K | — | Filing → |
| FDMT | SELL | 2026-08-04 | $125K | — | Filing → |
| FDMT | SELL | 2026-07-14 | $737K | — | Filing → |